For example, using a WTP threshold of $50 000/QALY, it is cost-effective to treat patients with a 2% or greater annual risk of developing glaucoma.
Using that same WTP threshold, treating those older than 65 years is only cost-effective with a 4% or greater annual risk of developing glaucoma.